US PoliticsThe company became the 17th drug manufacture to enter a Most Favored Nation prescription pricing agreement. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026. Alex Wong/Getty ImagesLawrence WilsonSenior Reporter4/23/2026|Updated: 4/23/20260:00Regeneron Pharmaceuticals on April 23 became the latest drug manufacturer to enter a Most Favored Nation drug pricing agreement with the United States.President Donald Trump announced the deal from the Oval Office.
17.6
C
Ottawa
Monday, June 15, 2026
The Alliance Press is the world leader in online chained news and information and seeks to inform, engage and empower the world. We expose the information that wasn't known before or current events broadcast over the radio, television, online or in print media. Our content is now available through your mobile phone. No matter where your on-the-go lifestyle takes you, TAP brings the news directly to you.
More from CN
Contact
© The Alliance Media Group design by CODEUS